Correction: Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial

Correction: Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial

Saved in:

Bibliographic Details
Main Authors:	M. M. B. Horstink, D. R. Geel, C. A. den Uil, P. E. Deetman, H. Endeman, A. Abdulla, T. M. Bosch, W. J. R. Rietdijk, F. W. Thielen, J. J. Haringman, P. van Vliet, T. A. Rijpstra, C. Bethlehem, A. Beishuizen, A. E. Muller, B. C. P. Koch, The BULLSEYE investigators
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Series:	BMC Infectious Diseases
Online Access:	https://doi.org/10.1186/s12879-025-10877-8
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial
by: M. M. B. Horstink, et al.
Published: (2025-03-01)

A New Formation Mechanism of Counterstreaming Mass Flows in Filaments and the Doppler Bullseye Pattern in Prominences
by: Chengrui Zhou, et al.
Published: (2025-01-01)

Impact of beta-lactam allergy labels on bone marrow transplant patients
by: Benjamin M. Haxby, et al.
Published: (2025-01-01)

PHARMACOKINETICS/PHARMACODYNAMICS OF A 8-LACTAM AND /8-LACTAMASE INHIBITOR COMBINATION: A NOVEL APPROACH FOR AZTREONAM/AVIBACTAM
by: R. .. Singh, et al.
Published: (2020-05-01)

Adjunctive β-lactams for bacteremia: a narrative review
by: Daniel B. Chastain, et al.
Published: (2025-06-01)

Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics
by: S. V. Yakovlev, et al.
Published: (2020-05-01)

Beiträge zur Chemie der β-Lactam-Antibiotika
by: J. Gosteli
Published: (1976-01-01)

Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
by: Namareq F. Aldardeer, et al.
Published: (2024-12-01)

Impact of Extending Beta-Lactam Infusions on IV Access Requirements
by: Kirstin J. Kooda, PharmD, et al.
Published: (2025-08-01)

Phage Anti-Pycsar Proteins Efficiently Degrade β-Lactam Antibiotics
by: Pallav Joshi, et al.
Published: (2024-10-01)

Non-beta-lactam agents for definitive treatment of ampicillin-susceptible Enterococcus bacteremia: a single-center experience
by: HeeEun Kang, et al.
Published: (2025-01-01)

Exploring β-lactam interactions with DacB1: unraveling optimal therapies for combating drug-resistant Mycobacterium tuberculosis
by: Mary Nantongo, et al.
Published: (2025-08-01)

3‑Hydroxy-Beta-Lactam Inhibitors of Dihydrofolate Synthetase
by: Brett Virgin-Downey, et al.
Published: (2025-06-01)

Staphylococcal phenotypes induced by naturally occurring and synthetic membrane-interactive polyphenolic β-lactam resistance modifiers.
by: Lucia Palacios, et al.
Published: (2014-01-01)

Beta-lactam antibiotics as reserve medications for the treatment of drug-resistant tuberculosis
by: G. N. Mozhokina, et al.
Published: (2021-08-01)

Characterization of YdgH: a mediator of beta-lactam susceptibility in Enterobacterales
by: Jacob E. Lazarus, et al.
Published: (2025-01-01)

Catalyst-Free Spontaneous Aza-Mannich/Lactamization Cascade Reaction: Easy Access to Polycyclic δ-Lactams
by: Antonia Di Mola, et al.
Published: (2025-06-01)

Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
by: Henrik Knecht, et al.
Published: (2014-01-01)

Novel approach to overcome the β-lactam resistant bacteria using an actinobacterial inhibitory protein
by: Nada A. M. Abdelbary, et al.
Published: (2023-10-01)

Deficiency in peptidoglycan recycling promotes β-lactam sensitivity in Caulobacter crescentus
by: Malvika Modi, et al.
Published: (2025-04-01)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022-07-01)

Purine and pyrimidine synthesis differently affect the strength of the inoculum effect for aminoglycoside and β-lactam antibiotics
by: Daniella M. Hernandez, et al.
Published: (2024-12-01)

Colistin and β-lactam resistance in Escherichia coli isolates from bovines, swine, and humans
by: Nayla Kellen de O Ventura, et al.
Published: (2025-01-01)

Dynamics of Beta-Lactams Resistance Distribution in Streptococcus pneumoniae and Its Clinical Significance
by: T. A. Savinova, et al.
Published: (2020-05-01)

Synthesis of Selective β-Lactam Derivatives
by: Iyad Ali, et al.
Published: (2012-11-01)

Oxidative Lactamization of Amino Alcohols: An Overview
by: Lakashima Sreerama, et al.
Published: (2020-02-01)

Associated resistance of Escherichia coli isolated from humans and animals to polymyxin and beta-lactam antibiotics
by: O. S. Sulian, et al.
Published: (2022-03-01)

Microbiological Risks to Health Associated with the Release of Antibiotic-Resistant Bacteria and β-Lactam Antibiotics Through Hospital Wastewater
by: Andres E. Nolasco-Rojas, et al.
Published: (2025-04-01)

Preparing a Compound of New Nanoparticles of Lactam, PE to Improve Their Specifications
by: Suad Muhsin Ali, et al.
Published: (2024-07-01)

Combatting <i>Pseudomonas aeruginosa</i> with β-Lactam Antibiotics: A Revived Weapon?
by: Dylan W. Zhao, et al.
Published: (2025-05-01)

Proportion of carbapenem-resistant Enterobacterales with readily detectable beta-lactam resistance
by: Eli Wilber, et al.
Published: (2025-01-01)

SNP Polymorphism in Genomes of CC320 Isolates of Streptococcus pneumoniae Resistant to Beta-Lactams
by: I. A. Tzvetkova, et al.
Published: (2020-05-01)

Medication Errors Associated with Beta-Lactam Antibiotics: Analysis of Russian Spontaneous Reporting Database
by: A. V. Kuzmina, et al.
Published: (2020-05-01)

Multiplex PCR for identification and β-lactam resistance gene detection in clinical isolates of Acinetobacter baumannii
by: Anh T Nguyen, et al.
Published: (2025-05-01)

Polyamide from lactams by reactive rotational molding via anionic ring-opening polymerization: Optimization of processing parameters
by: N. Barhoumi, et al.
Published: (2013-01-01)

Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients
by: Mohammad H. Alshaer, et al.
Published: (2025-05-01)

Council of Experts Resolution on the Use of Inhibitor-Protected Beta-Lactams in the Treatment of Community-Acquired and Nosocomial Infections 11 February , 2019, Moscow
by: A. V. Alekhin, et al.
Published: (2020-05-01)

392 Adjuvants for the potentiation of the activity of β-lactam antibiotics against methicillin-resistant Staphylococcus aureus
by: Caitlyn Thomas, et al.
Published: (2025-04-01)

Copy number flexibility facilitates heteroresistance to increasing antibiotic pressure and threatens the beta-lactam pipeline
by: Jacob E. Choby, et al.
Published: (2025-07-01)

Clinical Outcome of Intra-Arterial Embolization for Treatment of Patients with Pelvic Trauma
by: M. W. Barentsz, et al.
Published: (2011-01-01)